viernes, 22 de mayo de 2015

What Is a Blood and Marrow Stem Cell Transplant? - NHLBI, NIH

What Is a Blood and Marrow Stem Cell Transplant? - NHLBI, NIH


What Is a Blood and Marrow Stem Cell Transplant?

A blood and marrow stem cell transplant replaces a person's abnormal stem cells with healthy ones from another person (a donor). This procedure allows the recipient to get new stem cells that work properly.

Stem cells are found in bone marrow, a sponge-like tissue inside the bones. Stem cells develop into the three types of blood cells that the body needs:

  • Red blood cells, which carry oxygen through the body
  • White blood cells, which fight infection
  • Platelets (PLATE-lets), which help the blood clot
Small numbers of stem cells also are found in the blood and in the umbilical cord (the cord that connects a fetus to its mother's placenta).

Another type of stem cell, called an embryonic (em-bre-ON-ik) stem cell, can develop into any type of cell in the body. These cells aren't found in bone marrow.


Doctors use stem cell transplants to treat people who have:

  • Certain cancers, such as leukemia (lu-KE-me-ah). The high doses of chemotherapy and radiation used to treat some cancers can severely damage or destroy bone marrow. A transplant replaces the stem cells that the treatment destroyed.
  • Severe blood diseases, such as thalassemias (thal-a-SE-me-ahs), aplastic anemia (uh-NEE-me-uh), and sickle cell anemia. In these diseases, the body doesn't make enough red blood cells or they don't work properly.
  • Certain immune-deficiency diseases that prevent the body from making some kinds of white blood cells. Without these cells, a person can develop life-threatening infections. A transplant provides stem cells to replace the missing white blood cells.

Types of Transplants

The two main types of stem cell transplants are autologous (aw-TOL-o-gus) and allogenic (a-LO-jen-ik).

For an autologous transplant, your own stem cells are collected and stored for use later on. This works best when you still have enough healthy stem cells, even though you’re sick. If you have cancer, the cancer cells are removed or destroyed from the collected cells.

For an allogenic transplant, you get stem cells from a donor. The donor can be a relative (like a brother or sister) or an unrelated person. You also may get stem cells from umbilical cord blood donated by an unrelated person.

To prevent problems, the donor's stem cells should match yours as closely as possible. Donors and recipients are matched through a blood test called HLA tissue typing.

Collection Process

Stem cells used in transplants are collected from donors in several ways.

A procedure called apheresis (a-fer-E-sis) may be used. For this procedure, a needle is placed in the donor's arm to draw blood. Then, his or her blood is passed through a machine that removes the stem cells from the blood. The rest of the blood is returned to the donor.

Stem cells may be collected directly from a donor's pelvis. This procedure isn't used very much anymore because it must be done in a hospital using local or general anesthesia (AN-es-THE-ze-a). For this procedure, a hollow needle is inserted repeatedly into the pelvis, and marrow is sucked out of the bone.

Blood containing stem cells may be collected from an umbilical cord and placenta after a baby is born. The blood is frozen and stored at a cord blood bank for future use.


Stem cell transplants have serious risks. Some complications are life threatening. For some people, however, stem cell transplants are the best hope for a cure or a longer life.

Blood and Marrow Stem Cell Transplant Clinical Trials
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. To find clinical trials that are currently underway for Blood and Marrow Stem Cell Transplant,

Blood and Marrow Stem Cell Transplant in the News

May 19, 2015

NHLBI Media Availability: New Form of Interleukin-2 Could Be Fine-Tuned to Fight Disease
WHAT:  Scientists are reporting development of a new way to modify interleukin-2 (IL-2), a substance known as a cytokine that plays key roles in regulating immune system responses, in order to fine-tune its actions.  Harnessing the action of IL-2 in a controllable fashion is of clinical interest with potential benefit in a range of situations, including transplantation and autoimmune disease.

No hay comentarios:

Publicar un comentario